Work

Abstract B105: Characterization of the activity of AZD9291 in patients (pts) with T790M ‘negative’ advanced non-small cell lung cancer (aNSCLC)

Year: 2015

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-15-b105

Authors: Pasi A. Jänne, Enriqueta Felip, Dong-Wan Kim, Thomas John, Daniel E. Haggstrom, Myung-Ju Ahn, Kenneth S. Thress, Suzanne C. Jenkins, Helen Mann, Mireille V. Cantarini, Simon P. Dearden, James Chih-Hsin Yang

Institutions: Dana-Farber Cancer Institute, Vall d'Hebron Hospital Universitari, Seoul National University Hospital, Olivia Newton-John Cancer Research Institute, Levine Cancer Institute, Samsung Medical Center, AstraZeneca (United Kingdom), Sheffield Hallam University, National Taiwan University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2401263160

Cites:

Cited by:

Related to: 10